Institute for Glycomics and Sienna Diagnostics to develop novel cancer diagnostic

Institute for Glycomics
Researchers from the Institute for Glycomics and the University of Adelaide, have entered into an exclusive licensing deal with Sienna Cancer Diagnostics Ltd to commercialise a novel cancer diagnostic tool. Together, the teams of researchers have engineered a unique protein, called SubB2M, that binds specifically to a sugar molecule only present in cancer cells – a potential […]